210 related articles for article (PubMed ID: 36808864)
1. Type 1 diabetes management: Room for improvement.
Varkevisser RDM; Birnie E; Mul D; van Dijk PR; Aanstoot HJ; Wolffenbuttel BHR; van der Klauw MM
J Diabetes; 2023 Mar; 15(3):255-263. PubMed ID: 36808864
[TBL] [Abstract][Full Text] [Related]
2. Factors Associated With Achievement of Blood Pressure, Low-Density Lipoprotein Cholesterol (LDL-C), and Glycemic Targets for Primary Prevention of Cardiovascular Diseases Among High Cardiovascular Risk Malaysians in Primary Care.
Baharudin N; Ramli AS; Ramland SS; Badlie-Hisham NI; Mohamed-Yassin MS
J Prim Care Community Health; 2023; 14():21501319231191017. PubMed ID: 37551146
[TBL] [Abstract][Full Text] [Related]
3. Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.
Wan EYF; Fung CSC; Yu EYT; Chin WY; Fong DYT; Chan AKC; Lam CLK
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862945
[TBL] [Abstract][Full Text] [Related]
4. Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: a retrospective cohort study from a specialised diabetes centre in Denmark.
Safai N; Carstensen B; Vestergaard H; Ridderstråle M
BMJ Open; 2018 Mar; 8(3):e019214. PubMed ID: 29550776
[TBL] [Abstract][Full Text] [Related]
5. Differences in lipid and blood pressure measurements between individuals with type 1 diabetes and the general population: a cross-sectional study.
Varkevisser RDM; Mul D; Aanstoot HJ; Wolffenbuttel BHR; van der Klauw MM
BMJ Open; 2023 Oct; 13(10):e073690. PubMed ID: 37880169
[TBL] [Abstract][Full Text] [Related]
6. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
Boytsov S; Logunova N; Khomitskaya Y;
Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
[TBL] [Abstract][Full Text] [Related]
7. Hba1c, Blood Pressure, and Lipid Control in People with Diabetes: Japan Epidemiology Collaboration on Occupational Health Study.
Hu H; Hori A; Nishiura C; Sasaki N; Okazaki H; Nakagawa T; Honda T; Yamamoto S; Tomita K; Miyamoto T; Nagahama S; Uehara A; Yamamoto M; Murakami T; Shimizu C; Shimizu M; Eguchi M; Kochi T; Imai T; Okino A; Kuwahara K; Kashino I; Akter S; Kurotani K; Nanri A; Kabe I; Mizoue T; Kunugita N; Dohi S;
PLoS One; 2016; 11(7):e0159071. PubMed ID: 27437997
[TBL] [Abstract][Full Text] [Related]
8. HEMOGLOBIN A1C, BLOOD PRESSURE, AND LDL-CHOLESTEROL CONTROL AMONG HISPANIC/LATINO ADULTS WITH DIABETES: RESULTS FROM THE HISPANIC COMMUNITY HEALTH STUDY/STUDY OF LATINOS (HCHS/SOL).
Casagrande SS; Aviles-Santa L; Corsino L; Daviglus ML; Gallo LC; Espinoza Giacinto RA; Llabre MM; Reina SA; Savage PJ; Schneiderman N; Talavera GA; Cowie CC
Endocr Pract; 2017 Oct; 23(10):1232-1253. PubMed ID: 28816530
[TBL] [Abstract][Full Text] [Related]
9. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk management in people with type 1 diabetes: performance using three guidelines.
Varkevisser RDM; Birnie E; Vollenbrock CE; Mul D; van Dijk PR; van der Klauw MM; Veeze H; Wolffenbuttel BHR; Aanstoot HJ
BMJ Open Diabetes Res Care; 2022 Jul; 10(4):. PubMed ID: 35858715
[TBL] [Abstract][Full Text] [Related]
11. The consequences of failure to achieve targets of guidelines for prevention and treatment of diabetic complications in patients with type 1 diabetes.
Lithovius R; Harjutsalo V; Forsblom C; Saraheimo M; Groop PH
Acta Diabetol; 2015 Feb; 52(1):31-8. PubMed ID: 24849006
[TBL] [Abstract][Full Text] [Related]
12. Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data.
Amadid H; Clemmensen KKB; Vistisen D; Persson F; Jørgensen ME
Cardiovasc Diabetol; 2022 Nov; 21(1):255. PubMed ID: 36419118
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk factor management in patients with diabetes: Does management differ with disease duration?
Lo S; Leiter LA; Langer A; Tan M; Goldin L; Harris S; Yale JF; Ekoe JM; Lin PJ; Goodman SG; Yan AT
J Diabetes Complications; 2021 Oct; 35(10):107997. PubMed ID: 34332851
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular Risk Factor Targets and Cardiovascular Disease Event Risk in Diabetes: A Pooling Project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study.
Wong ND; Zhao Y; Patel R; Patao C; Malik S; Bertoni AG; Correa A; Folsom AR; Kachroo S; Mukherjee J; Taylor H; Selvin E
Diabetes Care; 2016 May; 39(5):668-76. PubMed ID: 27208374
[TBL] [Abstract][Full Text] [Related]
15. Association of ABC (HbA1c, blood pressure and LDL-cholesterol) goal achievement with visit-to-visit ABC variability and postprandial dysmetabolism in type 2 diabetic patients.
Kitaoka K; Takenouchi A; Minato-Inokawa S; Takeuchi M; Tsuboi A; Kurata M; Fukuo K; Kazumi T
Asia Pac J Clin Nutr; 2020; 29(3):476-482. PubMed ID: 32990606
[TBL] [Abstract][Full Text] [Related]
16. Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register.
Karlsson SA; Franzén S; Svensson AM; Miftaraj M; Eliasson B; Andersson Sundell K
BMC Health Serv Res; 2018 Nov; 18(1):900. PubMed ID: 30486824
[TBL] [Abstract][Full Text] [Related]
17. Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals?
Saposnik G; Goodman SG; Leiter LA; Yan RT; Fitchett DH; Bayer NH; Casanova A; Langer A; Yan AT; ; ;
Stroke; 2009 Apr; 40(4):1417-24. PubMed ID: 19213947
[TBL] [Abstract][Full Text] [Related]
18. Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008.
Kuznik A; Mardekian J
Cardiovasc Diabetol; 2011 Apr; 10():31. PubMed ID: 21496321
[TBL] [Abstract][Full Text] [Related]
19. Blood Pressure Management in Adults With Type 2 Diabetes: Insights From the Diabetes Mellitus Status in Canada (DM-SCAN) Survey.
Grenier J; Goodman SG; Leiter LA; Langer A; Teoh H; Bhatt DL; Cheng AYY; Tan MK; Ransom T; Connelly KA; Yan AT
Can J Diabetes; 2018 Apr; 42(2):130-137. PubMed ID: 28552652
[TBL] [Abstract][Full Text] [Related]
20. Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: comparison by prevalent cardiovascular disease status.
Wong ND; Patao C; Wong K; Malik S; Franklin SS; Iloeje U
Diab Vasc Dis Res; 2013 Nov; 10(6):505-13. PubMed ID: 23975724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
